Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity
Abstract Background The evaluation of treatment efficacy for individuals with fragile X syndrome (FXS) or intellectual disability (ID) more generally has been hampered by the lack of adequate outcome measures. We evaluated expressive language sampling (ELS) as a procedure for generating outcome meas...
Main Authors: | Leonard Abbeduto, Elizabeth Berry-Kravis, Audra Sterling, Stephanie Sherman, Jamie O. Edgin, Andrea McDuffie, Anne Hoffmann, Debra Hamilton, Michael Nelson, Jeannie Aschkenasy, Angela John Thurman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Journal of Neurodevelopmental Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s11689-020-09313-6 |
Similar Items
-
Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity
by: Leonard Abbeduto, et al.
Published: (2020-04-01) -
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling
by: Angela John Thurman, et al.
Published: (2021-04-01) -
The fragile X syndrome-autism comorbidity: what do we really know?
by: Leonard eAbbeduto, et al.
Published: (2014-10-01) -
Specificity: A Phenotypic Comparison of Communication-Relevant Domains Between Youth With Down Syndrome and Fragile X Syndrome
by: Laura del Hoyo Soriano, et al.
Published: (2018-10-01) -
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
by: Anna W. Lee, et al.
Published: (2018-12-01)